| Download a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
China is the world's most populous country and fastest growing major economy.
This report is ideal for executives wanting to understand the key drivers in
the pharmaceutical market and have access to a wealth of statistical data,
including five-year market projections. Included with the report are 3 free
quarterly updated outlook reports, enabling you to keep up to date with market
developments for a year.
China remains a very poor GDP country and pharmaceutical expenditure per
capita is similar to that in Pakistan or India. Increasingly China is becoming
a "2 track" country. While there are some very high quality hospitals and
clinics in the big cities, in rural areas facilities are badly-equipped, drugs
are in short supply and trained staff are lacking.
But that's just part of the story. The role of traditional Chinese medicine in
limiting the growth of western medicine, continuing issues about intellectual
property protection, the dominance of "copycat" drugs, a growing AIDS problem,
antibiotic resistance, the expansion of Chinese R&D and downward pressure in
drug pricing are all part of the mix.
TABLE OF CONTENTS
CHINA: BACKGROUND DATA
- ORGANISATION & ADMINISTRATION
- Ministry of Health
- Hospitals
- Rural Healthcare
- Health Insurance
- Rural Co-operative Medical Care System
- Commercial Medical Insurance
- Red Cross Society of China
- HEALTH EXPENDITURE
- Total Health Expenditure, 1995-2002 (Yuan billions)
- HOSPITAL SERVICES
- Healthcare Facilities
- Healthcare Institutions by Type, 2000-2003
- Hospitals by Type, 1998
- Healthcare Institutions by Type, 2002
- Healthcare Institutions by Type and Province, 2002
- Joint venture hospitals
- Hospital Beds
- Healthcare Beds, 1995-2003 (000s)
- Number of Beds in Healthcare Institutions by Type, 2000-2002
- Beds by Region, 2003
- Hospital Beds by Department, 2000 and 2002 (000s)
- Military Hospitals
- Private Hospitals
- Hospital Activity
- Hospital Admissions, 1999-2003 (millions)
- Hospital Bed Utilisation Statistics, 1992-2001
- Bed Occupancy Rates by Type of Hospital, 1992-2001 (%)
- Bed Turnover & Days in Use by Type of Hospital, 1992-2001
- AMBULATORY CARE
- Outpatient Facilities, 2000-2003
- Hospital Outpatient Activity
- Hospital Outpatient Visits, 1999-2001 (millions)
- MEDICAL PERSONNEL (22-39)
- Medical Personnel (000s), 2000-2003
- Middle and High Level Health Professionals, 1995-2001
- Medical Personnel by Province, 2003
- Medical Technical Personnel by Type of Institution, 1998 (000s)
- Number of Doctors by Department, 2000
- Rural Physician Reforms
CHINA: ACCESSING THE PHARMACEUTICAL MARKET
- INTRODUCTION
- REGULATORY ENVIRONMENT
- Pharmaceutical Registration
- State Food and Drug Administration (SFDA)
- Department of Drug Registration
- Department of Drug Safety & Inspection
- Department of Drug Market Compliance
- Drug Classification
- Biotech regulation
- New Regulatory Legislation
- 2001 DAL Amendments
- The Drug Import Regulation
- GMP Regulations
- Pharmaceutical Registration/Drug Approval Process
- Clinical trials
- Quality test
- Certification
- Packaging Regulations
- Post-market Surveillance
- Sector Development
- Pharmaceutical Advertising
- Sector Development
- Patent Protection & Intellectual Property Rights
- Administrative Protection
- Pharmaceutical Pricing and Reimbursement
- Pricing
- Pricing Sector Development
- Provincial governments
- Reimbursement Lists
- DISTRIBUTION CHANNELS
- Distribution System Reform
- Internet Pharmaceutical Distribution
- Pharmaceutical retail
- Distributors
- Chindex
- Hainan Kangtong Pharmaceutical Co Ltd.
- Hunan Provincial Medicines & Health Products Import & Export Corp.
- Shandong Medicines & Health Products Import & Export Corp.
- Sincer Pharmchem Ltd
- Sinochem Jiangsu Suzhou Import Export Corp
- Tianjin Medicines & Health Products Import & Export Corp.
- PHARMACEUTICAL IMPORTS
- Summary Pharmaceutical Imports, 1999-2003 (US$000s)
- Leading Suppliers of Raw Materials, 2003 (US$000s)
- Leading Suppliers of Medicaments, 2003 (US$000s)
- Imports of Pharmaceuticals, 1999-2003 (US$000s)
- Leading Suppliers, 2003 (U$000s)
- Leading Suppliers by Category, 2003 (US$000s)
- DOMESTIC PRODUCTION
- Chinese Medical/Pharmaceutical Production, 2001-02
- 10th Five Year Plan Targets
- Zhejiang pharmaceutical investment plans
- HIV/AIDS drugs
- Domestic Producers
- Anhui Anke Biotech
- Beijing Four Ring Pharmaceutical Factory
- Changzhou Siyao Pharmaceuticals Co. Ltd.
- China Pharmaceutical Enterprise
- Dragon Pharmaceuticals
- Dragon Pharmaceutical revenues, 2003-04 (US$ millions)
- Dragon Pharmaceutical revenues by Segment, Q1 2005 (US$ millions)
- Fuzhou Antibiotic Group Corp
- Haizhou Pharmaceutical Co. Ltd.
- Heshuo Ephedrine Factory
- Huazhong Pharmaceutical Co. Ltd.
- Jiangsu Jiangan Pharmaceutical Corp Ltd.
- Jiuyuan
- Livzon (Group) Libao Biochemical & Pharmaceutical Co Ltd.
- Ningbo Jierfu Pharmaceutical Co Ltd.
- North China Pharmaceutical Huasheng Co. Ltd.
- Shandong Xinhua Lukang Pharmaceutical Group
- Shenyang Sunshine Pharmaceutical Co Ltd.
- Shenzhen Kexing Biotech
- Shenzhen Pharmaceutical Factory
- Shenzhen Taitai Pharmaceutical Industry (Taitai)
- Wenzhou Pharmaceutical Factory
- Xiamen No.2 Pharmaceutical Factory
- Xi'an Pharmaceutical Factory
- Yiyuan Pharmaceutical Co Ltd
- Zhejiang Jinhua Lixin Fine Chemicals Co Ltd
- Multinational Producers
- Allergan
- Antibioticos
- AstraZeneca
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Daiichi Pharmaceutical Co. (China)
- Eli Lilly
- GlaxoSmithKline
- Johnson & Johnson
- Laboratories Servier
- Merck KGaA
- Merck Sharp & Dohme
- Novartis
- Novo Nordisk
- Pfizer
- Ranbaxy
- Rexim SA (Degussa)
- Roche
- Sankyo
- Sanofi-Synthelabo
- Schering-Plough
- Takeda
- Tanabe
- Valeant Pharmaceuticals
- Watson
- Yamanouchi
- Research & Development
- SFDA initiatives
- Zhangjiang Hi-Tech Park
- Beijing Union Pharmaceutical Factory
- AstraZeneca
- Summary Pharmaceutical Exports, 1999-2003 (US$000s)
- Exports of Pharmaceuticals 1999-2003
- Leading Destinations, 2003 (U$000s)
- Pharmaceutical Balance of Trade, 1999-2003
- DIRECTORY
CHARTS
- Imports of Raw Materials/Retail Medicaments, 1998-2003 (US$000s)
- Leading Suppliers, 2003 (%)
- Exports by Category, 2003 (%)
- Leading Destinations, 2003 (%)
|
